These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26599495)

  • 1. Managing juvenile idiopathic arthritis-associated uveitis.
    Hawkins MJ; Dick AD; Lee RJ; Ramanan AV; Carreño E; Guly CM; Ross AH
    Surv Ophthalmol; 2016; 61(2):197-210. PubMed ID: 26599495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile idiopathic arthritis in the new world of biologics.
    Ostring GT; Singh-Grewal D
    J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uveitis associated with juvenile idiopathic arthritis.
    Bou R; Iglesias E; Antón J
    Curr Rheumatol Rep; 2014 Aug; 16(8):437. PubMed ID: 24938442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
    Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K
    Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for juvenile idiopathic arthritis-associated uveitis.
    Richards JC; Tay-Kearney ML; Murray K; Manners P
    Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis.
    Kenawy N; Cleary G; Mewar D; Beare N; Chandna A; Pearce I
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):297-300. PubMed ID: 20922440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series.
    La Torre F; Cattalini M; Teruzzi B; Meini A; Moramarco F; Iannone F
    BMC Res Notes; 2014 May; 7():316. PubMed ID: 24886032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile idiopathic arthritis-associated uveitis.
    Sen ES; Ramanan AV
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):517-534. PubMed ID: 29773271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
    Cecchin V; Zannin ME; Ferrari D; Pontikaki I; Miserocchi E; Paroli MP; Bracaglia C; Marafon DP; Pastore S; Parentin F; Simonini G; De Libero C; Falcini F; Petaccia A; Filocamo G; De Marco R; La Torre F; Guerriero S; Martino S; Comacchio F; Muratore V; Martini G; Vittadello F; Zulian F
    J Rheumatol; 2018 Aug; 45(8):1167-1172. PubMed ID: 29657140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis.
    Kolomeyer AM; Tu Y; Miserocchi E; Ranjan M; Davidow A; Chu DS
    Ocul Immunol Inflamm; 2016 Aug; 24(4):377-85. PubMed ID: 26902465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis.
    Mangge H; Heinzl B; Grubbauer HM; El-Shabrawi Y; Schauenstein K
    Rheumatol Int; 2003 Sep; 23(5):258-61. PubMed ID: 12687288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    Birolo C; Zannin ME; Arsenyeva S; Cimaz R; Miserocchi E; Dubko M; Deslandre CJ; Falcini F; Alessio M; La Torre F; Denisova E; Martini G; Nikishina I; Zulian F
    J Rheumatol; 2016 Nov; 43(11):2068-2073. PubMed ID: 27633826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab in the therapy of uveitis in childhood.
    Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M
    Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient.
    Tsang AC; Roth J; Gottlieb C
    Ocul Immunol Inflamm; 2014 Apr; 22(2):155-7. PubMed ID: 24377416
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in uveitis of juvenile idiopathic arthritis.
    Kotaniemi K; Savolainen A; Karma A; Aho K
    Surv Ophthalmol; 2003; 48(5):489-502. PubMed ID: 14499817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab for juvenile idiopathic arthritis-associated uveitis.
    Magli A; Forte R; Navarro P; Russo G; Orlando F; Latanza L; Alessio M
    Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1601-6. PubMed ID: 23446556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?
    Foeldvari I; Petrushkin H
    Expert Rev Clin Immunol; 2024 Mar; 20(3):267-276. PubMed ID: 37990508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
    Quartier P; Baptiste A; Despert V; Allain-Launay E; Koné-Paut I; Belot A; Kodjikian L; Monnet D; Weber M; Elie C; Bodaghi B;
    Ann Rheum Dis; 2018 Jul; 77(7):1003-1011. PubMed ID: 29275333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.